With the results of the FLOW trial anticipated next year, as well as high rates of obesity and CVD in type 1 diabetes, there remains an unmet need for additional mechanistic and CVD/kidney outcome studies of GLP1-RAs in the population with type 1 diabetes and CKD [50]
At the top of this hierarchy, there is a small subpopulation, called cancer stem cells (CSCs) or tumor/initiating cells (TICs), which are critical not only for tumor initiation and progression but also for therapy resistance and metastasis
Patients are often offered: Corticosteroid injections quick pain relief, but they dont heal tissue
10.1056/NEJM196209132671105 286 SamsonS
Insights into the early use of oral semaglutide in routine clinical practice: the IGNITE study
MMNST, Malignant Melanotic Nerve Sheath Tumor